APPROVALS

Medicines for Malaria Venture (MMV) and healthcare non-profit PATH have launched a five-year initiative to support countries in elimination of Plasmodium vivax (P. vivax)...

Pfizer and Eli Lilly have reported top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study...

Ipsen has closed its acquisition of Canada’s Clementia Pharmaceuticals after securing approval from shareholders and the Quebec Superior Court. Clementia shareholders will receive $25.00 per...